bpi compounded tirzepatide with b6 labs is challenging the patent. This is a second challenge as Empower pharmacy was already challenging the patent. BPI includes additional imformation including a previous patent application showing GLP-1/GIP as BPI is BACK : r/tirzepatidecompound

The current study demonstrated that GLP-1RA is better at reducing liver fat content, BMI, and WC than TZD in overweight or obese patients with NAFLD or NASH

It affects areas of the brain that regulate appetite, leading to reduced hunger and increased feelings of fullness

Were excited to announce that the first #SetPointSystem procedure in North Carolina was completed in collaboration with Arthritis & Osteoporosis Consultants of the Carolinas (AOCC), the largest independent rheumatology practice in the Southeast

28 Lean patients with MASH and stage 2 or 3 fibrosis can receive either resmetirom or semaglutide, as FDA approval of these drugs was based on fibrosis stage rather than body mass index